Histoplasmosis Infections Worldwide: Thinking Outside of the Ohio River Valley

Current Tropical Medicine Reports

Volumn 2, Issue 2, 2015, Pages 70-80

  Bahr, Nathan C ^a   Antinori, Spinello ^b   Wheat, L Joseph ^c   Sarosi, George A ^a,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c MIRAVISTA DIAGNOSTICS   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome; Biologic drugs; H. capsulatum var. duboisii; Histoplasma capsulatum var. capsulatum; Histoplasmosis; Human immunodeficiency virus; Immunosuppression; Infectious diseases, emerging, travelers; Progressive disseminated histoplasmosis; Pulmonary fungal infections

Indexed keywords

CORTICOSTEROID; HISTOPLASMIN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; AJELLOMYCES CAPSULATUS; ASIA; BAT; CAVE; COMPOST; ENDEMIC DISEASE; EPIDEMIC; FUNGUS ISOLATION; GEOGRAPHIC DISTRIBUTION; HISTOPLASMOSIS; HUMAN; IMMIGRATION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MULTICENTER STUDY (TOPIC); NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOIL MICROFLORA; SOUTH AND CENTRAL AMERICA; TALAROMYCES MARNEFFEI; TRAVEL;

EID: 84977615899     PISSN: None     EISSN: 21963045     Source Type: Journal    
DOI: 10.1007/s40475-015-0044-0     Document Type: Review

References (113)

1. Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7):807–25.
2. Kuzma JF. Histoplasmosis; the pathologic and clinical findings. Dis Chest. 1947;13(4):338–44.
3. Christie A. Histoplasmosis and pulmonary calcification; geographic distribution. Am J Trop Med Hyg. 1951;31(6):742–52.
4. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis. 1969;99(4):1–132.
5. Londero AT, Fischman O, Ramos C. A critical review of medical mycology in Brazil 1946–1960. Mycopathol Mycol Appl. 1962;18:293–316.
6. Mochi A, Edwards PQ. Geographical distribution of histoplasmosis and histoplasmin sensitivity. Bull World Health Organ. 1952;5(3):259–91.
7. Sethi KK, Passi S. Histoplasmosis in India. A critical review. Mycopathol Mycol Appl. 1970;40(3):369–74.
8. Klugman HB, Lurie HI. Systemic histoplasmosis in South Africa. A review of the previous cases and a report of an additional case—the first successfully treated. S Afr Med J. 1963;37:29–31.
9. Knox KS, Hage CA. Histoplasmosis. Proc Am Thorac Soc. 2010;7(3):169–72.
10. Swartzentruber S, Rhodes L, Kurkjian K, et al. Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis. 2009;49(12):1878–82.
11. Medeiros AA, Marty SD, Tosh FE, Chin TD. Erythema nodosum and erythema multiforme as clinical manifestations of histoplasmosis in a community outbreak. N Engl J Med. 1966;274(8):415–20.
12. Loulergue P, Bastides F, Baudouin V, et al. Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients. Emerg Infect Dis. 2007;13(11):1647–52.
13. Antinori S, Magni C, Nebuloni M, et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore). 2006;85(1):22–36.
14. Nacher M, Adenis A, Blanchet D, et al. Risk factors for disseminated histoplasmosis in a cohort of HIV-infected patients in French Guiana. PLoS Negl Trop Dis. 2014;8(1):e2638. This retrospective review convincingly shows an inverse risk of PDH with CD4+ T-cell count.
15. Ozols II, Wheat LJ. Erythema nodosum in an epidemic of histoplasmosis in Indianapolis. Arch Dermatol. 1981;117(11):709–12.
16. Rosenthal J, Brandt KD, Wheat LJ, Slama TG. Rheumatologic manifestations of histoplasmosis in the recent Indianapolis epidemic. Arthritis Rheum. 1983;26(9):1065–70.
17. Assi MA, Sandid MS, Baddour LM, Roberts GD, Walker RC. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore). 2007;86(3):162–9.
18. Wheat LJ, Batteiger BE, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore). 1990;69(4):244–60.
19. Jones PG, Cohen RL, Batts DH, Silva Jr J. Disseminated histoplasmosis, invasive pulmonary aspergillosis, and other opportunistic infections in a homosexual patient with acquired immune deficiency syndrome. Sex Transm Dis. 1983;10(4):202–4.
20. Kaur J, Myers AM. Homosexuality, steroid therapy, and histoplasmosis. Ann Intern Med. 1983;99(4):567.
21. Pasternak J, Bolivar R. Histoplasmosis in acquired immunodeficiency syndrome (AIDS): diagnosis by bone marrow examination. Arch Intern Med. 1983;143(10):2024.
22. Sathapatayavongs B, Batteiger BE, Wheat J, Slama TG, Wass JL. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore). 1983;62(5):263–70.
23. Small CB, Klein RS, Friedland GH, Moll B, Emeson EE, Spigland I. Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. Am J Med. 1983;74(3):433–41.
24. Wheat LJ, Slama TG, Zeckel ML. Histoplasmosis in the acquired immune deficiency syndrome. Am J Med. 1985;78(2):203–10.
25. Haggerty CM, Britton MC, Dorman JM, Marzoni Jr FA. Gastrointestinal histoplasmosis in suspected acquired immunodeficiency syndrome. West J Med. 1985;143(2):244–6.
26. Bartholomew C, Raju C, Patrick A, Penco F, Jankey N. AIDS on Trinidad. Lancet. 1984;1(8368):103.
27. Vithayasai P, Vithayasai V. Clinical manifestations of 174 AIDS cases in Maharaj Nakorn Chiang Mai Hospital. J Dermatol. 1993;20(7):389–93.
28. Geffray L, Veyssier P, Cevallos R, et al. [African histoplasmosis: clinical and therapeutic aspects, relation to AIDS. Apropos of 4 cases, including a case with HIV-1-HTLV-1 co-infection]. Ann Med Interne (Paris). 1994;145(6):424–8.
29. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore). 1990;69(6):361–74.
30. Antinori S. Histoplasma capsulatum: more widespread than previously thought. Am J Trop Med Hyg. 2014;90(6):982–3.
31. Hajjeh RA, Pappas PG, Henderson H, et al. Multicenter case–control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis. 2001;32(8):1215–20.
32. Myint T, Anderson AM, Sanchez A, et al. Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse. Medicine (Baltimore). 2014;93(1):11–8.
33. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308(4):387–402.
34. Ajello L, Zeidberg LD. Isolation of Histoplasma capsulatum and Allescheria boydii from soil. Science. 1951;113(2945):662–3.
35. Emmons CW. Isolation of Histoplasma capsulatum from soil. Public Health Rep. 1949;64(28):892–6.
36. Ajello L. Relationship of Histoplasma capsulatum to avian habitats. Public Health Rep. 1964;79:266–70.
37. Zhao B, Xia X, Yin J, et al. Epidemiological investigation of Histoplasma capsulatum infection in China. Chin Med J (Engl). 2001;114(7):743–6.
38. C.T. H. Histoplasmin and coccidiodin sensitivity among students in Taiwan. J Formos Med Assoc. 1953;4:549–54.
39. Jayanetra PP R, Satapathayawong B, Atichartrakarn V, Thianprasit M, Waropastrakul C, Poopaibul K, et al. The magnitude of the public health problem posed by the Mycoses. Part II: the lack of information. J Infect Dis Antimicrob Agents. 1987;4:175–84.
40. Bezjak V, Farsey SJ. Prevalence of skin sensitivity to histoplasmin and coccidioidin in various Ugandan populations. Am J Trop Med Hyg. 1970;19(4):664–9.
41. Mangiaterra M, Alonso J, Galvan M, Giusiano G, Gorodner J. Histoplasmin and paracoccidioidin skin reactivity in infantile population of northern Argentina (1). Rev Inst Med Trop Sao Paulo. 1996;38(5):349–53.
42. Rodrigues MT, de Resende MA. Epidemiologic skin test survey of sensitivity to paracoccidioidin, histoplasmin and sporotrichin among gold mine workers of Morro Velho Mining, Brazil. Mycopathologia. 1996;135(2):89–98.
43. Carmona J. Analisis estadistico y ecologico-epidemiologico de la sensibilidad a la histoplasmina en Colombia 1950–1968. Antioquia Med. 1971;21:109–54.
44. Mok WY, Netto CF. Paracoccidioidin and histoplasmin sensitivity in Coari (state of Amazonas), Brazil. Am J Trop Med Hyg. 1978;27(4):808–14.
45. Diogenes MJ, Goncalves HM, Mapurunga AC, Alencar KF, Andrade FB, Nogueira-Queiroz JA. Histoplasmin and paracoccidioidin reactions in Serra de Pereiro. (Ceara State–Brazil). Rev Inst Med Trop Sao Paulo. 1990;32(2):116–20.
46. Zembrzuski MM, Bassanesi MC, Wagner LC, Severo LC. [An intradermal test with histoplasmin and paracoccidioidin in 2 regions of Rio Grande do Sul]. Rev Soc Bras Med Trop. 1996;29(1):1–3.
47. Cermeno JR, Cermeno JJ, Hernandez I, et al. Histoplasmine and paracoccidiodine epidemiological study in Upata, Bolivar state, Venezuela. Trop Med Int Health. 2005;10(3):216–9.
48. Pedroza-Seres M, Quiroz-Mercado H, Granados J, Taylor ML. The syndrome of presumed ocular histoplasmosis in Mexico: a preliminary study. J Med Vet Mycol. 1994;32(2):83–92.
49. Taylor ML, Perez-Mejia A, Yamamoto-Furusho JK, Granados J. Immunologic, genetic and social human risk factors associated to histoplasmosis: studies in the State of Guerrero, Mexico. Mycopathologia. 1997;138(3):137–42.
50. Cermeno JR, Hernandez I, Cermeno JJ, et al. Epidemiological survey of histoplasmine and paracoccidioidine skin reactivity in an agricultural area in Bolivar state, Venezuela. Eur J Epidemiol. 2004;19(2):189–93.
51. Suarez Fernandez MFACM, Estrada Ortiz A, Cisneiros Despaigne E. Reactividad a la histoplasmina en trabajadores de granajas avicolas en la provincia de Ciego de Avila, Cuba. Rev Inst Med Trop Sao Paulo. 1992;34:329–33.
52. Gugnani HC, Egere JU, Larsh H. Skin sensitivity to capsulatum and duboisii histoplasmins in Nigeria. J Trop Med Hyg. 1991;94(1):24–6.
53. Wen FQ, Sun YD, Watanabe K, Yoshida M, Wu JN, Baum GL. Prevalence of histoplasmin sensitivity in healthy adults and tuberculosis patients in southwest China. J Med Vet Mycol. 1996;34(3):171–4.
54. Randhawa HS. Occurrence of histoplasmosis in Asia. Mycopathol Mycol Appl. 1970;41(1):75–89.
55. Bulmer AC, Bulmer GS. Incidence of histoplasmin hypersensitivity in the Philippines. Mycopathologia. 2001;149(2):69–71.
56. Hay RJ, White HS, Fields PE, Quamina DB, Dan M, Jones TR. Histoplasmosis in the eastern Caribbean: a preliminary survey of the incidence of the infection. J Trop Med Hyg. 1981;84(1):9–12.
57. de Lambert Cremeur Y, Drouhet E. [Aspects of histoplasmosis in French possessions in the Americas]. Bull Soc Pathol Exot Filiales. 1972;65(4):499–506.
58. Muotoe-Okafor FA, Gugnani HC, Gugnani A. Skin and serum reactivity among humans to histoplasmin in the vicinity of a natural focus of Histoplasma capsulatum var. duboisii. Mycopathologia. 1996;134(2):71–4.
59. Nuti M, Tarabini GC, Adorisio E, Zardi O. Histoplasmosis diffusion in Somalia: study of skin-test and serological survey. Biochem Exp Biol. 1979;15(2):111–7.
60. Pan B, Chen M, Pan W, Liao W. Histoplasmosis: a new endemic fungal infection in China? Review and analysis of cases. Mycoses. 2013;56(3):212–21. This large review analyzed 300 cases of histoplasmosis in China over the preceding 30 years, most cases were PDH and most were related to advanced HIV.
61. Pan B, Deng S, Liao W, Pan W. Endemic mycoses: overlooked diseases in China. Clin Infect Dis. 2013;56(10):1516–7.
62. Chakrabarti A, Slavin MA. Endemic fungal infections in the Asia-Pacific region. Med Mycol. 2011;49(4):337–44.
63. Wang TL, Cheah JS, Holmberg K. Case report and review of disseminated histoplasmosis in South-East Asia: clinical and epidemiological implications. Trop Med Int Health. 1996;1(1):35–42.
64. Kikuchi K, Sugita T, Makimura K, et al. Is Histoplasma capsulatum a native inhabitant of Japan? Microbiol Immunol. 2008;52(9):455–9.
65. Norkaew T, Ohno H, Sriburee P, et al. Detection of environmental sources of Histoplasma capsulatum in Chiang Mai, Thailand, by nested PCR. Mycopathologia. 2013;176(5–6):395–402.
66. Ponnampalam J. Isolation of Histoplasma capsulatum from the soil of a cave in Central Malaya. Am J Trop Med Hyg. 1963;12:775–6.
67. Jing W, Ismail R. Mucocutaneous manifestations of HIV infection: a retrospective analysis of 145 cases in a Chinese population in Malaysia. Int J Dermatol. 1999;38(6):457–63.
68. Ohno H, Ogata Y, Suguro H, et al. An outbreak of histoplasmosis among healthy young Japanese women after traveling to Southeast Asia. Intern Med. 2010;49(5):491–5.
69. Gopalakrishnan R, Nambi PS, Ramasubramanian V, Abdul Ghafur K, Parameswaran A. Histoplasmosis in India: truly uncommon or uncommonly recognised? J Assoc Physicians India. 2012;60:25–8.
70. McLeod DS, Mortimer RH, Perry-Keene DA, et al. Histoplasmosis in Australia: report of 16 cases and literature review. Medicine (Baltimore). 2011;90(1):61–8.
71. Couppie P, Aznar C, Carme B, Nacher M. American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis. Curr Opin Infect Dis. 2006;19(5):443–9.
72. Huber F, Nacher M, Aznar C, et al. AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana. AIDS. 2008;22(9):1047–53.
73. Mata-Essayag S, Colella MT, Rosello A, et al. Histoplasmosis: a study of 158 cases in Venezuela, 2000–2005. Medicine (Baltimore). 2008;87(4):193–202.
74. Nacher M, Adenis A, Mc Donald S, et al. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis. 2013;7(11):e2319.
75. Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol. 2011;49(8):785–98.
76. Vantilcke V, Boukhari R, Jolivet A, et al. Fever in hospitalized HIV-infected patients in Western French Guiana: first think histoplasmosis. Int J STD AIDS. 2014;25(9):656–61. This retrospective study analyzed HIV infected patients hospitalized with a febrile illness. The findings of the study are striking in that while 41% of these patients with CD4+ cell counts <200 had PDH, over 85% of those patients with CD4+ cell counts < 50 had PDH. This is an incredibly important finding for this region.
77. Arango M, Castaneda E, Agudelo CI, et al. Histoplasmosis: results of the Colombian national survey, 1992–2008. Biomedica. 2011;31(3):344–56.
78. Corti MEN R, Esquivel P, Villafane MF. Histoplasmosis diseminada en paziente con SIDA: analisis epidemiologico, clinico, microbiologico e inmunologico de 26 pacientes. Enf Emerg. 2004;6:8–15.
79. Prado M, Silva MB, Laurenti R, Travassos LR, Taborda CP. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz. 2009;104(3):513–21.
80. Gugnani HC, Muotoe-Okafor F. African histoplasmosis: a review. Rev Iberoam Micol. 1997;14(4):155–9.
81. Williams AO, Lawson EA, Lucas AO. African histoplasmosis due to Histoplasma duboisii. Arch Pathol. 1971;92(5):306–18.
82. Khalil MA, Hassan AW, Gugnani HC. African histoplasmosis: report of four cases from north-eastern Nigeria. Mycoses. 1998;41(7–8):293–5.
83. Coulanges P. Large-form histoplasmosis (H. duboisii) in Madagascar (apropos of 3 cases). Arch Inst Pasteur Madagascar. 1989;56(1):169–74.
84. Coulanges P, Raveloarison G, Ravisse P. [Existence of Histoplasma duboisii histoplasmosis outside continental Africa (apropos of the first Madagascar case)]. Bull Soc Pathol Exot Filiales. 1982;75(4):400–3.
85. Garcia-Guinon A, Torres-Rodriguez JM, Ndidongarte DT, Cortadellas F, Labrin L. Disseminated histoplasmosis by Histoplasma capsulatum var. duboisii in a paediatric patient from the Chad Republic, Africa. Eur J Clin Microbiol Infect Dis. 2009;28(6):697–9.
86. Oddo D, Etchart M, Thompson L. Histoplasmosis duboisii (African histoplasmosis). An African case reported from Chile with ultrastructural study. Pathol Res Pract. 1990;186(4):514–7.
87. Gumbo T, Just-Nubling G, Robertson V, Latif AS, Borok MZ, Hohle R. Clinicopathological features of cutaneous histoplasmosis in human immunodeficiency virus-infected patients in Zimbabwe. Trans R Soc Trop Med Hyg. 2001;95(6):635–6.
88. KR P, Mosam A, Dlova NC NBS, Aboobaker J, Singh SM. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J Cutan Pathol. 2002;29(4):215–25.
89. Inojosa W, Rossi MC, Laurino L, et al. Progressive disseminated histoplasmosis among human immunodeficiency virus-infected patients from West-Africa: report of four imported cases in Italy. Infez Med. 2011;19(1):49–55.
90. Lofgren SM, Kirsch EJ, Maro VP, et al. Histoplasmosis among hospitalized febrile patients in northern Tanzania. Trans R Soc Trop Med Hyg. 2012;106(8):504–7.
91. Gascon J, Torres JM, Luburich P, Ayuso JR, Xaubet A, Corachan M. Imported histoplasmosis in Spain. J Travel Med. 2000;7(2):89–91.
92. Morgan J, Cano MV, Feikin DR, et al. A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001. Am J Trop Med Hyg. 2003;69(6):663–9.
93. Alonso D, Munoz J, Letang E, et al. Imported acute histoplasmosis with rheumatologic manifestations in Spanish travelers. J Travel Med. 2007;14(5):338–42.
94. Garcia-Vazquez E, Velasco M, Gascon J, Corachan M, Mejias T, Torres-Rodriguez JM. [Histoplasma capsulatum infection in a group of travelers to Guatemala]. Enferm Infecc Microbiol Clin. 2005;23(5):274–6.
95. Nasta P, Donisi A, Cattane A, Chiodera A, Casari S. Acute histoplasmosis in spelunkers returning from Mato Grosso, Peru. J Travel Med. 1997;4(4):176–8.
96. Weinberg M, Weeks J, Lance-Parker S, et al. Severe histoplasmosis in travelers to Nicaragua. Emerg Infect Dis. 2003;9(10):1322–5.
97. Centers for Disease C, Prevention. Outbreak of histoplasmosis among travelers returning from El Salvador—Pennsylvania and Virginia, 2008. MMWR Morb Mortal Wkly Rep. 2008;57(50):1349–53.
98. Centers for Disease C. Cave-associated histoplasmosis—Costa Rica. MMWR Morb Mortal Wkly Rep. 1988;37(20):312–3.
99. Salomon J, Flament Saillour M, De Truchis P, et al. An outbreak of acute pulmonary histoplasmosis in members of a trekking trip in Martinique, French West Indies. J Travel Med. 2003;10(2):87–93.
100. Lyon GM, Bravo AV, Espino A, et al. Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998–1999. Am J Trop Med Hyg. 2004;70(4):438–42.
101. Buxton JA, Dawar M, Wheat LJ, et al. Outbreak of histoplasmosis in a school party that visited a cave in Belize: role of antigen testing in diagnosis. J Travel Med. 2002;9(1):48–50.
102. Valdez H, Salata RA. Bat-associated histoplasmosis in returning travelers: case presentation and description of a cluster. J Travel Med. 1999;6(4):258–60.
103. Buitrago MJ, Bernal-Martinez L, Castelli MV, Rodriguez-Tudela JL, Cuenca-Estrella M. Histoplasmosis and paracoccidioidomycosis in a non-endemic area: a review of cases and diagnosis. J Travel Med. 2011;18(1):26–33.
104. Cottle LE, Gkrania-Klotsas E, Williams HJ, et al. A multinational outbreak of histoplasmosis following a biology field trip in the Ugandan rainforest. J Travel Med. 2013;20(2):83–7.
105. Kajfasz P, Basiak W. Outbreak of pulmonary histoplasmosis involving a group of four Polish travellers returning from Ecuador. Int Marit Health. 2012;63(1):59–62.
106. Norman FF, Martin-Davila P, Fortun J, et al. Imported histoplasmosis: two distinct profiles in travelers and immigrants. J Travel Med. 2009;16(4):258–62.
107. Taylor ML, Ruiz-Palacios GM, del Rocio R-MM, et al. Identification of the infectious source of an unusual outbreak of histoplasmosis, in a hotel in Acapulco, state of Guerrero, Mexico. FEMS Immunol Med Microbiol. 2005;45(3):435–41.
108. Hage CA, Bowyer S, Tarvin SE, Helper D, Kleiman MB, Wheat LJ. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis. 2010;50(1):85–92. This study reviewed a relatively large number of cases of histoplasmosis associated with TNF-α inhibitor use, the majority of which were PDH. In addition, the study brings out the importance of considering immune reconstitution inflammatory syndrome with removal of the offending immunosuppressive agent.
109. Olson TC, Bongartz T, Crowson CS, Roberts GD, Orenstein R, Matteson EL. Histoplasmosis infection in patients with rheumatoid arthritis, 1998–2009. BMC Infect Dis. 2011;11:145. This single center study make two important points. Patients with rheumatoid arthritis are at risk of histoplasmosis even if on minimal or no immune suppression; however, if a patient with rheumatoid arthritis is on immune supressive therapy, the likelyhood of the infection progressing to PDH is much higher.
110. Assi M, Martin S, Wheat LJ, et al. Histoplasmosis after solid organ transplant. Clin Infect Dis. 2013;57(11):1542–9. This large retrospective multi-center study of solid organ transplant patients with histoplasmosis. The study encompassed 152 infections at 24 centers and characterized transplant type, immune suppression used, the type of infection as well as mortality in this population.
111. Ende N, Pizzolato P, Ziskind J. Hodgkin’s disease associated with histoplasmosis. Cancer. 1952;5(4):763–9.
112. Deepe Jr GS, Wuthrich M, Klein BS. Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity. Med Mycol. 2005;43(5):381–9.
113. Marianelli LG, Frassone N, Marino M, Debes J. Immune reconstitution inflammatory syndrome as histoplasmosis osteomyelitis in South America. AIDS. 2014;28(12):1848–50.